Sands Capital Management - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sands Capital Management ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$249,703,421
+10.7%
1,570,363
-1.5%
0.85%
+21.4%
Q2 2023$225,512,561
-17.1%
1,594,179
-1.3%
0.70%
-21.9%
Q1 2023$271,876,314
+90040.2%
1,614,851
-9.4%
0.90%
-21.3%
Q4 2022$301,615
-99.9%
1,781,439
+8.7%
1.14%
-1.0%
Q3 2022$306,666,0001,638,9591.15%
Other shareholders
REPLIGEN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders